CYT-6091
N/A
Report date: 2024/12/24 16:11:57
Base Information
Drug NameCYT-6091
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[12]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesCytlmmune
China Registration ClassN/A
Develop Information
Active CompaniesCytlmmune
Inactive CompaniesNational Institutes Of Health Clinical Center (Cc)
Active Indications
Inactive Indications +[11]
Other Information
ATC CodeN/A
Related LinksN/A